medRxiv PreprintsInternational18 November 2026
Evaluation of a Study Advisory Group on the Facilitators and Barriers to Patient Engagement
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
The facilitators and barriers to patient engagement in an advisory group (AG) were evaluated. The AG was formed to provide the patient voice in the development of a pragmatic trial to study multinutrient treatment in children with ADHD. The AG consisted of patient partners (those with lived experience and caregivers) and healthcare professionals (those working with children with ADHD). Eleven AG members completed the Patient Engagement in Research Scale, and five members participated in semi-structured interviews. Qualitative data were analyzed thematically, and five themes were identified. To
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.